Restricted accessResearch articleFirst published online 2025-6
Radial Extracorporeal Shockwave Therapy (rESWT) Is Not Superior to “Minimal-Dose” rESWT for Patients With Chronic Noninsertional Achilles Tendinopathy: A Double-Anonymized Randomized Controlled Trial
Outcomes following radial extracorporeal shockwave therapy (rESWT) in patients with chronic noninsertional Achilles tendinopathy are investigated.
Methods:
Patients with chronic noninsertional Achilles tendinopathy were recruited from a single National Health Services clinic, randomized equally to either “therapeutic” or “minimal-dose” (“presumed sham”) rESWT (3 sessions at weekly intervals). Both groups had an identical structured home rehabilitation program of progressive loading, balance, and stretching exercises.
Results:
Fifty-seven patients were recruited; mean age 49.7±7.2 years, 60% female, symptom duration: 22.2±19.5 months. No between-group differences were identified at the final or any interim time points. Clinically and statistically significant within-group improvements were identified in pain/local function patient-reported outcome measures for both groups, with “average pain” improving by 34% at 6 months. No consistent benefits were seen in global function, activity levels, or mood.
Conclusion:
“Recommended-dose” rESWT is not superior to “minimal-dose” rESWT and may be ineffective for patients with chronic noninsertional Achilles tendinopathy.
Al-AbbadHSimonJV.The effectiveness of extracorporeal shock wave therapy on chronic Achilles tendinopathy: a systematic review. Foot Ankle Int. 2013;34(1):33-41.
2.
ArbabDKuhlmannKSchnurrCLüringCKönigDBouillonB.Comparison of the Manchester–Oxford Foot Questionnaire (MOXFQ) and the Self-Reported Foot and Ankle Outcome Score (SEFAS) in patients with foot or ankle surgery. Foot Ankle Surg. 2019;25(3):361-365. doi:10.1016/j.fas.2018.01.003
3.
Barker-DaviesRBakerPWatsonJ, et al. High-volume image-guided injections in Achilles and patellar tendinopathy in a young active military population: a double-blind randomized controlled trial. Orthop J Sports Med. 2022;10(4):23259671221088326. doi:10.1177/23259671221088326
4.
BennettMISmithBHTorranceNPotterJ.The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain2005;6(3):149-158. doi:10.1016/j.jpain.2004.11.007
5.
BoesenAPLangbergHHansenRMalliarasPBoesenMI. High-volume injection with and without corticosteroid in chronic midportion Achilles tendinopathy. Scand J Med Sci Sports. 29(8):1223-1231. doi:10.1111/sms.13450
6.
Budiman-MakEConradKJRoachKE.The Foot Function Index: a measure of foot pain and disability. J Clin Epidemiol. 1991;44(6):561-570. doi:10.1016/0895-4356(91)90220-4
7.
ChanOO’DowdDPadhiarN, et al. High volume image guided injections in chronic Achilles tendinopathy. Disabil Rehabil. 2008;30(20-22):1697-1708. doi:10.1080/09638280701788225
8.
ChenWCloostermanKLABierma-ZeinstraSMAvan MiddelkoopMde VosR-J.Epidemiology of insertional and midportion Achilles tendinopathy in runners: a prospective cohort study. J Sport Health Sci. 2024:13(2):256-263. doi:10.1016/j.jshs.2023.03.007
9.
ColemanKJNgorEReynoldsK, et al. Initial validation of an exercise “vital sign” in electronic medical records. Med Sci Sports Exerc. 2012;44(11):2071-2076.
10.
CopayAGGlassmanSDSubachBRBervenSSchulerTCCarreonLY.Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and Pain Scales. Spine J. 2008;8(6):968-974. doi:10.1016/j.spinee.2007.11.006
11.
CraigCLMarshallALSjostromM, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395.
12.
DawsonJBollerIDollH, et al. Responsiveness of the Manchester–Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Joint Surg Br. 2012;94-B(2):215-221. doi:10.1302/0301-620x.94b2.27634
13.
de JongeSVan Den BergCde VosRJ, et al. Incidence of midportion Achilles tendinopathy in the general population. Br J Sports Med. 2011;45(13):1026-1028. doi:10.1136/bjsports-2011-090342
14.
de VosR-JVan der VlistACWintersMVan der GiesenFWeirA.Diagnosing Achilles tendinopathy is like delicious spaghetti carbonara: it is all about key ingredients, but not all chefs use the same recipe. Br J Sports Med. 2021;55(5):247-248. doi:10.1136/bjsports-2020-102863
FanYFengZCaoJFuW.Efficacy of extracorporeal shock wave therapy for Achilles tendinopathy: a meta-analysis. Orthop J Sports Med. 2020;8(2):2325967120903430. doi:10.1177/2325967120903430
17.
GauffinJHankamaTKautiainenHHannonenPHaanpääM.Neuropathic pain and use of PainDETECT in patients with fibromyalgia: a cohort study. BMC Neurol. 2013;13:21. doi:10.1186/1471-2377-13-21
18.
HerdmanMGudexCLloydA, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.
19.
JanssenMFPickardASGolickiD, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22(7):1717-1727.
20.
JespersenAAmrisKBliddalH, et al. Is neuropathic pain underdiagnosed in musculoskeletal pain conditions? The Danish PainDETECTive study. Curr Med Res Opin. 2010;26(8):2041-2045. doi:10.1185/03007995.2010.502748
21.
KediaMWilliamsMJainL.The effects of conventional physical therapy and eccentric strengthening for insertional Achilles tendinopathy. Int J Sports Phys Ther. 2014;9(4):488-497.
22.
KellyAM.The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001;18(3):205-207. doi:10.1136/emj.18.3.205
23.
KorakakisVWhiteleyRTzavaraAMalliaropoulosN.The effectiveness of extracorporeal shockwave therapy in common lower limb conditions: a systematic review including quantification of patient-rated pain reduction. Br J Sports Med. 2018;52(6):387-407. doi:10.1136/bjsports-2016-097347
24.
KroenkeKSpitzerRLWilliamsJBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x
25.
LandorfKBRadfordJA.Minimal important difference: values for the Foot Health Status Questionnaire, Foot Function Index and visual analogue scale. The Foot. 2008;18(1):15-19. doi:10.1016/j.foot.2007.06.006
26.
LöweBDeckerOMüllerS, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274. doi:10.1097/MLR.0b013e318160d093
27.
LöweBKroenkeKHerzogWGräfeK.Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61-66. doi:10.1016/S0165-0327(03)00198-8
28.
MalliarasP.Physiotherapy management of Achilles tendinopathy. J Physiother. 2022;68(4):221-237. doi:10.1016/j.jphys.2022.09.010
29.
Mani-BabuSMorrisseyDWaughCScreenHBartonC.The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: a systematic review. Am J Sports Med. 2015;43(3):752-761. doi:10.1177/0363546514531911
30.
MartinJPerratonLGuptaAGarofoliniAMalliarasP.The use of physical function capacity measures in the management of lower limb tendinopathy: a scoping review of expert recommendations. Phys Ther Sport. 2023;59:37-48. doi:10.1016/j.ptsp.2022.12.002
31.
MartinRLChimentiRCuddefordT, et al. Achilles pain, stiffness, and muscle power deficits: midportion Achilles tendinopathy revision 2018. J Orthop Sports Phys Ther. 2018;48(5):A1-A38. doi:10.2519/jospt.2018.0302
32.
MartinRLIrrgangJJBurdettRGContiSFSwearingenJMV. Evidence of validity for the Foot and Ankle Ability Measure (FAAM). Foot Ankle Int. 2005;26(11):968-983. doi:10.1177/107110070502601113
33.
MorleyDJenkinsonCDollH, et al. The Manchester–Oxford Foot Questionnaire (MOXFQ): development and validation of a summary index score. Bone Joint Res. 2013;2(4):66-69. doi:10.1302/2046-3758.24.2000147
34.
NeblettRCohenHChoiY, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438-445. doi:10.1016/j.jpain.2012.11.012
35.
NorrisRCookJLGaidaJEMaddoxTRajuJO’NeillS.The VISA-A (sedentary) should be used for sedentary patients with Achilles tendinopathy: a modified version of the VISA-A developed and evaluated in accordance with the COSMIN checklist. Br J Sports Med. 2023;57(20):1311-1316. doi:10.1136/bjsports-2022-105547
36.
RabusinCLMenzHBMcClellandJA, et al. Efficacy of heel lifts versus calf muscle eccentric exercise for mid-portion Achilles tendinopathy (HEALTHY): a randomised trial. Br J Sports Med. 2021;55(9):486-492. doi:10.1136/bjsports-2019-101776
37.
RadovanovićGBohmSPeperKKArampatzisALegerlotzK.Evidence-based high-loading tendon exercise for 12 weeks leads to increased tendon stiffness and cross-sectional area in Achilles tendinopathy: a controlled clinical trial. Sports Med Open. 2022;8(1):149. doi:10.1186/s40798-022-00545-5
38.
RasmussenSChristensenMMathiesenISimonsonO.Shockwave therapy for chronic Achilles tendinopathy: a double-blind, randomized clinical trial of efficacy. Acta Orthop. 2008;79(2):249-256. doi:10.1080/17453670710015058
39.
RobinsonJMCookJLPurdamC, et al. The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med. 2001;35(5):335-341. doi:10.1136/bjsm.35.5.335
40.
RompeJDNafeBFuriaJPMaffulliN.Eccentric loading, shock-wave treatment, or a wait-and-see policy for tendinopathy of the main body of tendo Achillis: a randomized controlled trial. Am J Sports Med. 2007;35(3):374-383. doi:10.1177/0363546506295940
41.
SalaffiFStancatiAAlberto SilvestriCCiapettiAGrassiW.Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283-291. doi:10.1016/j.ejpain.2003.09.004
42.
SallisR.Developing healthcare systems to support exercise: exercise as the fifth vital sign. Br J Sports Med. 2011;45(6):473-474. doi:10.1136/bjsm.2010.083469
43.
SmarrKLKeeferAL.Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res. 2011;63(S11):S454-S466. doi:10.1002/acr.20556
44.
SnaithRPZigmondAS.The Hospital Anxiety and Depression Scale manual. Nfer-Nelson; 1994.
45.
SooHooNFSamimiDBVyasRMBotzlerT.Evaluation of the validity of the Foot Function Index in measuring outcomes in patients with foot and ankle disorders. Foot Ankle Int. 2006;27(1):38-42. doi:10.1177/107110070602700107
46.
SpeedC.A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence. Br J Sports Med. 2014;48(21):1538-1542. doi:10.1136/bjsports-2012-091961
47.
TashjianRZDeloachJPorucznikCAPowellAP.Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease. J Shoulder Elbow Surg. 2009;18(6):927-932. doi:10.1016/j.jse.2009.03.021
48.
VahdatpourBForouzanHMomeniFAhmadiMTaheriP.Effectiveness of extracorporeal shockwave therapy for chronic Achilles tendinopathy: a randomized clinical trial. J Res Med Sci. 2018;23:37. doi:10.4103/jrms.JRMS_413_16
49.
van der VlistACBredaSJOeiEHGVerhaarJANde VosR-J.Clinical risk factors for Achilles tendinopathy: a systematic review. Br J Sports Med. 2019;53(21):1352-1361. doi:10.1136/bjsports-2018-099991
50.
VicenzinoBde VosR-JAlfredsonH, et al. ICON 2019—International Scientific Tendinopathy Symposium Consensus: There are nine core health-related domains for tendinopathy (CORE DOMAINS): Delphi study of healthcare professionals and patients. Br J Sports Med. 2020;54(8):444-451. doi:10.1136/bjsports-2019-100894
51.
VulpianiMCTrischittaDTrovatoPVetranoMFerrettiA.Extracorporeal shockwave therapy (ESWT) in Achilles tendinopathy: a long-term follow-up observational study. J Sports Med Phys Fitness. 2009;49(2):171-176.
52.
WeingartenTNWatsonJCHootenWM, et al. Validation of the S-LANSS in the community setting. Pain. 2007;132(1):189-194. doi:10.1016/j.pain.2007.07.030
53.
WheelerPDudsonCCalverR, et al. Three sessions of radial-extra-corporeal shockwave therapy (rESWT) gives no additional benefit over “minimal-dose” rESWT for patients with chronic greater trochanteric pain syndrome (GTPS), a double-blinded randomised controlled trial. Clin J Sport Med. 2022;32(1):e7-e18. doi:10.1097/JSM.0000000000000880
54.
WheelerPMahadevanDBhattRBhatiaM.A comparison of two different high-volume image-guided injection procedures for patients with chronic non-insertional Achilles tendinopathy. J Foot Ankle Surg. 2016;55(5):976-979. doi:10.1053/j.jfas.2016.04.017
55.
WheelerPC.The use of high-volume image-guided injections (HVIGI) for Achilles tendinopathy - a case series & pilot study. Int Musculoskelet Med. 2014;36(3):96-103.
56.
WheelerPC.Neuropathic pain may be common in chronic lower limb tendinopathy; a prospective cohort study. Br J Pain. 2017;11(1):16-22. doi:10.1177/2049463716680560
57.
WheelerPC.Up to a quarter of patients with certain chronic recalcitrant tendinopathies may have central sensitisation – a prospective cohort of more than 300 patients. Br J Pain. 2019;13(3):137-144. doi:10.1177/2049463718800352
58.
WheelerPC.Nearly half of patients with chronic tendinopathy may have a neuropathic pain component, with significant differences seen between different tendon sites – a prospective cohort of more than 300 patients. BMJ Open Sport Exerc Med. 2022;8:e001297. doi:10.1136/bmjsem-2021-001297
59.
WheelerPCDudsonCCalverR.Radial extracorporeal shockwave therapy (rESWT) is not superior to “minimal-dose” rESWT for patients with chronic plantar fasciopathy; a double-blinded randomised controlled trial. Foot Ankle Surg. 2022;28(8):1356-1365. doi:10.1016/j.fas.2022.06.016
60.
WheelerPCDudsonCCalverR.Radial extracorporeal shockwave therapy (rESWT) is not superior to “minimal-dose” rESWT for patients with chronic patella tendinopathy; a double-blinded-randomised-controlled-trial. Muscles Ligaments Tendons J. 2023;13(4):531-540. doi:10.32098/mltj.04.2023.03
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
